OHSU in the news

22nd annual Doernbecher freestyle auction

KPTV October 21, 2026
The annual Doernbecher Freestyle auction, featuring custom Nike shoes designed by six pediatric patients, raised a record-breaking $2.4 million to support OHSU Doernbecher Children’s Hospital, including patient care, research initiatives and plans for an expanded neonatal and maternal-child services. Dana Braner, M.D., says, “A founding principle of Doernbecher was that it would be a lifesaving resource for kids and their families, regardless of their ability to pay. And that principle has become a promise that still stands firm today, thanks in huge part to the continuous support we receive from the community.”

Why more non-smokers are being diagnosed with lung cancer

This Morning with Gordon Deal October 20, 2026
Christopher Slatore, M.D., is interviewed in light of Pope Leo’s recent diagnosis and treatment for lung cancer. In the interview on This Morning with Gordon Deal, he says, “We’ve known for a long time that cigarette smoke is the most common and biggest reason that people get lung cancer. But we’re seeing more and more people who don’t have a history of smoking get lung cancer as well.”

OHSU urges safe gun storage after deadly Bend school shooting

KGW-TV October 20, 2026
In the wake of the tragedy in Bend, OHSU official urge community members to safely store firearms in their homes, especially if there are children present. Shereef Elnahal, M.D., says the Tom Sargent Safety Center can offer safety consultations to anyone in the state, and provides firearm storage options at a discount.

OHSU warns of pediatric care strain as flu season approaches

KGW-TV October 20, 2026
Oregon is entering respiratory virus season and encourages people to get vaccinated against flu, RSV (respiratory syncytial virus) and COVID-19 to reduce severe illness and prevent additional strain on hospitals, particularly pediatric services. Shereef Elnahal, M.D., says, “Influenza, RSV, COVID — all of these infectious diseases spike at the very same time — and we’re getting into that time. Right now, vaccination is one of the most important things you can do to protect your kids and protect yourself.”

Medical experts urge caution this flu season to avoid overwhelming hospitals

The Lund Report October 20, 2026
Local media report that that Oregon is entering respiratory virus season and encourages people to get vaccinated against flu, RSV (respiratory syncytial virus) and COVID-19 to reduce severe illness and prevent additional strain on hospitals, particularly pediatric services. Shereef Elnahal, M.D., says, “Influenza, RSV, COVID — all of these infectious diseases spike at the very same time — and we’re getting into that time. Right now, vaccination is one of the most important things you can do to protect your kids and protect yourself.”

La Center woman one of first stroke patients to receive new device at OHSU

The Columbian October 20, 2026
The Columbian profiles a stroke survivor from La Center, Washington, as she undergoes treatment at OHSU with an innovative implanted device designed to help restore function after stroke. OHSU was the first in Oregon to implant the vagus nerve stimulation device for stroke rehabilitation. Ahmed Raslan, M.D., says, “This will be life-altering treatment for a lot of patients. It opens up a new era in bioelectronic medicine."

OHSU secures $12.5M for research on ubiquitin signaling and its role in disease prevention

KGW-TV October 19, 2026
OHSU scientists from multiple disciplines are collaborating to better understand ubiquitin biology and develop insights that could lead to new therapies for a wide range of diseases with $12.5 million in new funding. Jonathan Pruneda, Ph.D., says, “Most people think of ubiquitin as a tag for protein degradation. But it can do a lot more than that, and a lot of what ubiquitin actually signals for is still a mystery.”

Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

Business Wire October 19, 2026
Pfizer Inc. reports results from an ongoing Phase 2 study investigating a new drug for adults with moderate-to-sever atopic dermatitis. Eric Simpson, M.D., says, “Systemic treatment in moderate-to-severe atopic dermatitis has moved from broad immunosuppression to targeted therapy, and that shift has meaningfully changed what we can offer patients.”

Nike Unveils the 2026 Doernbecher Freestyle Collection

House of Heat October 18, 2026
The annual Doernbecher Freestyle auction, featuring custom Nike shoes designed by six pediatric patients, raised a record-breaking $2.4 million to support OHSU Doernbecher Children’s Hospital, including patient care, research initiatives and plans for an expanded neonatal and maternal-child services.
See more stories